Biopsy Needle Market size is estimated at USD 1.7 billion in 2024 and is likely to exceed USD 3.8 billion by the end of 2037, expanding at over 7.1% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of biopsy needle is evaluated at USD 1.9 billion.
The biopsy needle market is rapidly expanding due to the rising prevalence of various chronic diseases. Biopsy needles play a crucial role in the healthcare sector, enabling healthcare professionals to gain accurate diagnosis results and develop effective treatment schedules. With advancements in technology and continuous research and development in this domain, the focus is shifting toward minimally invasive procedures, expanding healthcare infrastructure, and result-oriented outcomes. Furthermore, automated and image-guided biopsy needles induce market demand enhancing precision and reducing tissue trauma. This market emphasizes needle designing, manufacturing, and distribution to conduct biopsy procedures for the end users with an effortless and time-saving approach leading to improved diagnostics accuracy and reliability.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
7.1% |
Base Year Market Size (2024) |
USD 1.7 billion |
Forecast Year Market Size (2037) |
USD 3.8 billion |
Regional scope |
|
Product (Biopsy Needle Guns, Biopsy Needles)
Biopsy needle guns segment is poised to hold over 64.1 % biopsy needle market share by the end of 2037. Biopsy needle guns are crucial in treating patients in procedures requiring rapid, accurate, and efficient results. The features associated with biopsy guns that make the procedure more effortless are their adjustable needle depth, handheld designs, and availability in various sizes. Biopsy needle guns offer enhanced accuracy, and reduce risks and complications, with valuable outcomes for healthcare professionals, and practitioners. The demand for biopsy guns has improved efficiency in healthcare settings and has led the field toward a revolutionized and advanced approach to diagnostics.
Application (Cancer, Autoimmune Disorder, Infectious Diseases)
The cancer segment is expected to register a staggering CAGR throughout the forecast period. Breast cancer and prostate cancer are the most highlighted sub-segments of cancer applications. The diverse range of emerging cancer cases has increased the demand for biopsy needles making it a significant diagnostics tool. In July 2021, GE Healthcare installed Serena Bright, the first-contrast-guided biopsy solution in 5 leading hospitals in the U.S. to support clinicians and patients in their fight against breast cancer.
Our in-depth analysis of the biopsy needle market includes the following segments:
Product |
|
Application |
|
End user |
|
North America Market Statistics
North America biopsy needle market is estimated to account for revenue share of more than 41.2% by the end of 2037 owing to the presence of advanced healthcare infrastructure and significant investments in medical research and development, fostering innovation and adoption of cutting-edge biopsy technologies. A robust regulatory framework enhancing trust and confidence among healthcare professionals and patients is expected to further boost the market growth.
The biopsy needle market in the U.S. is expected to register a significant revenue share during the forecast period owing to increasing prevalence of several chronic diseases, rising availability of different types of biopsy needles, and presence of advanced healthcare infrastructure. Moreover, the public and private sectors are heavily investing in R&D activities to develop and launch advanced biopsy needles for better results.
APAC Market Analysis
Asia Pacific biopsy needle market is driven by a significant increase in the demand for minimally invasive procedures and a rise in cancer across the region. Factors that add to this surge include increasing investments in liquid biopsy techniques, rising inclination toward personalized healthcare, and a high adoption of advanced diagnostic tools in healthcare centers in APAC.
In India, the biopsy needle market is likely to experience an upsurge owing to enhancing healthcare system infrastructure, and government initiatives. Key Players in this region including Boston Scientific and Medtronic play a vital role in revolutionizing the scenario of diagnostics procedures and preparation of systematized treatment plans.
The biopsy needle market is highly competitive, consisting of key players operating at global and regional levels. The key players are focused on developing advanced tools and products to cater to the rising demand for effective diagnostic tools. These key players are also adopting several strategies such as joint ventures, acquisitions, and product launches to sustain their market position and enhance their product base. Here’s a list of key players operating in the global market:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?